Our mission is to build the world's most used longevity biomarkers.We have built digital biomarkers for biological age and resilience. The technology behind GeroSense is based on years of scientific research in fundamental aspects of human aging, models borrowed from thermodynamics, and AI/DL models taught on large biomedical datasets. This research behind and proof-of-concept use of GeroSense were published in leading scientific journals, including Nature Communications.GeroSense can be used to assess lifestyle, nutraceutical, and therapeutic interventions in humans as a separate digital aging clock or in combination with molecular aging clocks to estimate the efficacy of the intervention on human biological age. GeroSense empowers nutraceutical companies to test their products, generate meaningful human data at a cost of animal trials, and publish the findings in peer-reviewed scientific journals.The GeroSense API engine can empower health tech, wellness companies, and longevity clinics to assess the efficacy of personalized recommendations and improve user engagement with a compelling metric of Biological Age Acceleration. PepsiCo, the Humanity app, and National University of Singapore already trust GeroSense to power their trials and calculations.GeroSense technology can be sampled in a free mobile app for iOS (search for GeroSense in App Store).GeroSense is a part of Gero.ai.